Related references
Note: Only part of the references are listed.A 300 IR sublingual tablet is an effective, safe treatment for house dust mite?induced allergic rhinitis: An international, double-blind, placebo-controlled, randomized phase III clinical trial
Pascal Demoly et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2021)
Japanese guidelines for allergic rhinitis 2020
Kimihiro Okubo et al.
ALLERGOLOGY INTERNATIONAL (2020)
EAACI Allergen Immunotherapy User's Guide
Montserrat Alvaro-Lozano et al.
PEDIATRIC ALLERGY AND IMMUNOLOGY (2020)
Allergic rhinitis
Jean Bousquet et al.
NATURE REVIEWS DISEASE PRIMERS (2020)
Duration of allergen immunotherapy for inhalant allergy
Martin Penagos et al.
CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY (2019)
Efficacy of house dust mite sublingual tablet in the treatment of allergic rhinoconjunctivitis: A randomized trial in a pediatric population
Yoshitaka Okamoto et al.
PEDIATRIC ALLERGY AND IMMUNOLOGY (2019)
EAACI Guidelines on Allergen Immunotherapy: Allergic rhinoconjunctivitis
G. Roberts et al.
ALLERGY (2018)
House dust mite sublingual tablet is effective and safe in patients with allergic rhinitis
Y. Okamoto et al.
ALLERGY (2017)
Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines-2016 revision
Jan L. Brozek et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2017)
Respiratory allergy caused by house dust mites: What do we really know?
Moises A. Calderon et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2015)
Can we predict allergen-induced asthma in patients with allergic rhinitis?
A. Buslau et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2014)
Efficacy and safety of sublingual tablets of house dust mite allergen extracts in adults with allergic rhinitis
Karl-Christian Bergmann et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2014)
The IgE repertoire in children and adolescents resolved at component level: A cross-sectional study
Giovanni Melioli et al.
PEDIATRIC ALLERGY AND IMMUNOLOGY (2012)
Share Paper
